Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,898 Cr
down ₹408 Cr vs Feb 2026
- Stocks held
- 35
- unchanged
- Top 10 weight
- 58.9%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 6, trimmed 29
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In March 2026 it disclosed 35 stocks worth ₹7,898 Cr, down ₹408 Cr from Feb 2026. Its largest positions were Sun Pharmaceutical Industries Limited (13.9%), Lupin Limited (8.4%), Divi's Laboratories Limited (6.4%); the ten largest together made up 58.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.3% of its equity. Cash and debt stood at 0.5%. Compared with Feb 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
26%
Holds more stocks than 26% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in March 2026
Download CSVEvery line the fund disclosed, with the change against Feb 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.92%
- Δ weight
- up 0.84 pts
- Value
- ₹1,099 Cr
- Δ value
- up ₹12.6 Cr
- Status
- Added
- Weight
- 8.45%
- Δ weight
- up 0.46 pts
- Value
- ₹667 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 6.41%
- Δ weight
- down 0.16 pts
- Value
- ₹506 Cr
- Δ value
- down ₹39.3 Cr
- Status
- Trimmed
- Weight
- 5.96%
- Δ weight
- up 0.15 pts
- Value
- ₹471 Cr
- Δ value
- down ₹11.8 Cr
- Status
- Trimmed
- Weight
- 5.42%
- Δ weight
- down 0.26 pts
- Value
- ₹428 Cr
- Δ value
- down ₹43.3 Cr
- Status
- Trimmed
- Weight
- 5.15%
- Δ weight
- down 0.01 pts
- Value
- ₹407 Cr
- Δ value
- down ₹22.1 Cr
- Status
- Trimmed
- Weight
- 3.86%
- Δ weight
- up 0.16 pts
- Value
- ₹305 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 3.36%
- Δ weight
- down 0.05 pts
- Value
- ₹265 Cr
- Δ value
- down ₹17.9 Cr
- Status
- Trimmed
- Weight
- 3.24%
- Δ weight
- down 0.26 pts
- Value
- ₹256 Cr
- Δ value
- down ₹34.5 Cr
- Status
- Trimmed
- Weight
- 3.15%
- Δ weight
- down 0.34 pts
- Value
- ₹249 Cr
- Δ value
- down ₹41.3 Cr
- Status
- Trimmed
- Weight
- 3.15%
- Δ weight
- up 0.07 pts
- Value
- ₹248 Cr
- Δ value
- down ₹6.7 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.19 pts
- Value
- ₹227 Cr
- Δ value
- down ₹27.4 Cr
- Status
- Trimmed
- Weight
- 2.81%
- Δ weight
- up 0.31 pts
- Value
- ₹222 Cr
- Δ value
- up ₹14.3 Cr
- Status
- Added
- Weight
- 2.77%
- Δ weight
- up 0.25 pts
- Value
- ₹219 Cr
- Δ value
- up ₹9.9 Cr
- Status
- Added
- Weight
- 2.64%
- Δ weight
- down 0.19 pts
- Value
- ₹208 Cr
- Δ value
- down ₹26.4 Cr
- Status
- Trimmed
- Weight
- 2.43%
- Δ weight
- up 0.06 pts
- Value
- ₹192 Cr
- Δ value
- down ₹4.6 Cr
- Status
- Trimmed
- Weight
- 2.17%
- Δ weight
- down 0.03 pts
- Value
- ₹172 Cr
- Δ value
- down ₹11 Cr
- Status
- Trimmed
- Weight
- 2.09%
- Δ weight
- up 0.11 pts
- Value
- ₹165 Cr
- Δ value
- up ₹87 L
- Status
- Added
- Weight
- 2.02%
- Δ weight
- down 0.03 pts
- Value
- ₹160 Cr
- Δ value
- down ₹10.7 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- down 0.14 pts
- Value
- ₹154 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Weight
- 1.90%
- Δ weight
- down 0.04 pts
- Value
- ₹150 Cr
- Δ value
- down ₹10.9 Cr
- Status
- Trimmed
- Weight
- 1.72%
- Δ weight
- down 0.04 pts
- Value
- ₹136 Cr
- Δ value
- down ₹10.1 Cr
- Status
- Trimmed
- Weight
- 1.67%
- Δ weight
- down 0.14 pts
- Value
- ₹132 Cr
- Δ value
- down ₹18.6 Cr
- Status
- Trimmed
- Weight
- 1.51%
- Δ weight
- up 0.20 pts
- Value
- ₹119 Cr
- Δ value
- up ₹10.4 Cr
- Status
- Added
- Weight
- 1.16%
- Δ weight
- up 0.01 pts
- Value
- ₹91.8 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 1.12%
- Δ weight
- down 0.15 pts
- Value
- ₹88.8 Cr
- Δ value
- down ₹16.9 Cr
- Status
- Trimmed
- Weight
- 1.11%
- Δ weight
- down 0.14 pts
- Value
- ₹87.8 Cr
- Δ value
- down ₹16.3 Cr
- Status
- Trimmed
- Weight
- 0.94%
- Δ weight
- down 0.16 pts
- Value
- ₹73.9 Cr
- Δ value
- down ₹17.4 Cr
- Status
- Trimmed
- Weight
- 0.93%
- Δ weight
- down 0.03 pts
- Value
- ₹73.4 Cr
- Δ value
- down ₹6.1 Cr
- Status
- Trimmed
- Weight
- 0.89%
- Δ weight
- up <0.01 pts
- Value
- ₹70.6 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 0.88%
- Δ weight
- down 0.01 pts
- Value
- ₹69.5 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 0.67%
- Δ weight
- down 0.37 pts
- Value
- ₹53 Cr
- Δ value
- down ₹33.5 Cr
- Status
- Trimmed
- Weight
- 0.62%
- Δ weight
- down 0.05 pts
- Value
- ₹48.6 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.54%
- Δ weight
- up 0.23 pts
- Value
- ₹42.6 Cr
- Δ value
- up ₹17.3 Cr
- Status
- Added
- Weight
- 0.38%
- Δ weight
- down 0.07 pts
- Value
- ₹30.1 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 0.14%
- Δ weight
- down 0.02 pts
- Value
- ₹11.4 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
What changed, Feb 2026 to Mar 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Aurobindo Pharma Limitedup ₹14.3 Cr (+0.31% pts)
- Sun Pharmaceutical Industries Limitedup ₹12.6 Cr (+0.84% pts)
- Emcure Pharmaceuticals Limitedup ₹10.4 Cr (+0.20% pts)
- IPCA Laboratories Limitedup ₹9.9 Cr (+0.25% pts)
- Lupin Limited ₹3.5 Cr (+0.46% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2026, the weight rose most in Pharmaceuticals & Biotechnology (+1.1 pts) and Retailing (+0.2 pts), and fell most in Healthcare Services (−1.2 pts).
- Pharmaceuticals & Biotechnology74.2% → 75.3%+1.1 pts
- Retailing3.7% → 3.9%+0.2 pts
- Healthcare Services21.7% → 20.5%−1.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2023 | Mar 2025 | Sep 2025 | Dec 2025 | Feb 2026 | Mar 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.0% | 77.1% | 75.8% | 74.7% | 74.2% | 75.3% |
| Healthcare Services | 19.4% | 18.9% | 20.1% | 21.1% | 21.7% | 20.5% |
| Retailing | 1.9% | 3.4% | 3.4% | 3.6% | 3.7% | 3.9% |
| Pharmaceuticals | 1.4% | 0.5% | 0.7% | 0.5% | 0.4% | 0.4% |
Allocation in Mar 2026change vs Feb 2026
- Pharmaceuticals & Biotechnology (24)75.3%▲ 1.1 pts
- Healthcare Services (9)20.5%▼ 1.2 pts
- Retailing (1)3.9%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2026
0.5%
▲ 0.2 pts vs Feb 2026
- Cash alone
- 0.6%
- cash and net receivables
- A year earlier
- 0.5%
- Mar 2025
- Last 12 months
- 0.3% – 2.6%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.